Hematologic Activity Alteration
- Name
- Hematologic Activity Alteration
- Accession Number
- DBCAT004469
- Description
Not Available
- Drugs
Drug Drug Description Pentoxifylline A methylxanthine derivative used to treat intermittent claudication caused by chronic occlusive arterial disease of the limbs. - Drugs & Drug Targets
Drug Target Type Pentoxifylline 5'-nucleotidase target Pentoxifylline Adenosine receptor A1 target Pentoxifylline Adenosine receptor A2a target Pentoxifylline Cytochrome P450 1A2 enzyme Pentoxifylline Phosphodiesterase enzymes target